Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} El presente comunicado de prensa no constituye una...
-
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Ce communiqué de presse ne constitue pas une offre...
-
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} This press release does not constitute an offer in...
-
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} This press release does not constitute an offer in...
-
RELAX-AHF study met one of its two primary endpoints in reducing dyspnea or shortness of breath, and showed RLX030 (serelaxin) was well tolerated[1] Six-month study shows that investigational...
-
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Geneva, Switzerland, 24 September 2012 - Addex...
-
Zurich / Switzerland, 24 September 2012 - ARYZTA AG announces financial results for the financial year ended 31 July 2012. The news release can be downloaded from the following link: ...
-
Positive opinion for the use of vildagliptin, with or without metformin, in combination with a stable dose of insulin[1] Additional positive opinion for the use of vildagliptin in combination...
-
Votubia (everolimus) would be the first non-surgical treatment option in the EU for kidney tumors associated with tuberous sclerosis complex (TSC)[1] Kidney tumors, or renal angiomyolipomas,...
-
Zurich / Switzerland, 19 September 2012 ARYZTA AG's 68.8% subsidiary; Origin Enterprises Plc, which is listed on the AIM in London (OGN) and the ESM in Dublin (OIZ), has announced its full year...